BDBM463307 (-)-(3R)-1-(benzimidazol-4- ylmethyl)-N-(9-chloro-3,4- dihydro-2H-1,5- benzodioxepin-7-ylmethyl)-N- isobutylpyrrolidine-3- carboxamide::US10780095, Structure TABLE 1.5

SMILES CC(C)CN(Cc1cc(Cl)c2OCCCOc2c1)C(=O)C1CCN(Cc2cccc3nc[nH]c23)C1

InChI Key

Data  2 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 463307   

TargetProkineticin receptor 2(Homo sapiens (Human))
The Regents of The University of California

US Patent
LigandPNGBDBM463307((-)-(3R)-1-(benzimidazol-4- ylmethyl)-N-(9-chloro-...)
Affinity DataKi:  1.70nMAssay Description:An aequorin-based luminescent assay for calcium mobilization was used to measure mobilization of intracellular Ca2+ (Bullock et al., Mol Pharmacol 65...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProkineticin receptor 1(Homo sapiens (Human))
The Regents of The University of California

US Patent
LigandPNGBDBM463307((-)-(3R)-1-(benzimidazol-4- ylmethyl)-N-(9-chloro-...)
Affinity DataKi:  2.60nMAssay Description:An aequorin-based luminescent assay for calcium mobilization was used to measure mobilization of intracellular Ca2+ (Bullock et al., Mol Pharmacol 65...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent